Related Experiment Videos
Dendritic cells require maturation via CD40 to generate protective antitumor immunity
M F Mackey1, J R Gunn, C Maliszewsky
1Department of Microbiology, Dartmouth Medical School, Lebanon, NH 03756, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|September 2, 1998
Summary
CD40/CD154 interactions are crucial for effective anti-tumor immunity by supporting T-helper 1 (Th1) cytokine production and dendritic cell (DC) function. Restoring IL-12 production in DCs can overcome deficits in anti-tumor responses.
Area of Science:
- Immunology
- Cancer Research
- Cell Biology
Background:
- CD40/CD154 interactions are vital for anti-tumor immunity.
- Deficiencies in these interactions impair T-helper 1 (Th1) responses and systemic tumor immunity.
Purpose of the Study:
- To investigate the role of CD40/CD154 in tumor immunity.
- To determine the impact on Th1 cytokine production and dendritic cell (DC) function.
- To explore strategies for restoring anti-tumor responses.
Main Methods:
- Studied CD40/CD154 deficient mice and tumor vaccination models.
- Assessed Th1-type cytokine production and DC maturation/function in vivo.
- Utilized IL-12-transduced tumor vaccines and co-administration of dendritic cells.
Main Results:
- Absence of CD40/CD154 signaling inhibited Th1 cytokine production and systemic tumor immunity.
- CD40-dependent DC maturation and function are critical for anti-tumor responses.
- IL-12-transduced vaccines restored anti-tumor immunity in mice lacking CD40/CD154 interactions.
Conclusions:
- Impaired anti-tumor immunity due to CD40/CD154 absence stems from defective antigen-presenting cell (APC) function, specifically IL-12 production.
- CD40 signaling is essential for dendritic cell maturation and function in vivo.
- Targeting IL-12 production in DCs presents a viable strategy to enhance anti-tumor immunity.